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Objective: We undertook a meta-analysis of published Randomized Controlled
Trials (RCT) with semi-active control and sham-NF groups to determine whether
Electroencephalogram-neurofeedback (EEG-NF) significantly improves the overall
symptoms, inattention and hyperactivity/impulsivity dimensions for probably unblinded
assessment (parent assessment) and probably blinded assessment (teacher assessment)
in children with Attention Deficit Hyperactivity Disorder (ADHD).
Data sources: A systematic review identified independent studies that were eligible for
inclusion in a random effects meta-analysis.
Data extraction: Effect sizes for ADHD symptoms were expressed as standardized mean
differences (SMD) with 95% confidence intervals.
Results: Five identified studies met eligibility criteria, 263 patients with ADHD were
included, 146 patients were trained with EEG-NF. On parent assessment (probably
unblinded assessment), the overall ADHD score (SMD = −0.49 [−0.74, −0.24]), the
inattention score (SMD = −0.46 [−0.76, −0.15]) and the hyperactivity/impulsivity score
(SMD = −0.34 [−0.59, −0.09]) were significantly improved in patients receiving EEG-NF
compared to controls. On teacher assessment (probably blinded assessment), only the
inattention score was significantly improved in patients receiving EEG-NF compared to
controls (SMD = −0.30 [−0.58, −0.03]).
Conclusions: This meta-analysis of EEG-NF in children with ADHD highlights improvement
in the inattention dimension of ADHD symptoms. Future investigations should pay greater
attention to adequately blinded studies and EEG-NF protocols that carefully control the
implementation and embedding of training.
Keywords: attention deficit hyperactivity disorder, neurofeedback, randomized controlled trial, learning, practice
guidelines
INTRODUCTION
The techniques of neurofeedback (NF) enable a patient to train
him or herself to self-regulate a single measure of brain activ-
ity (Coben and Evans, 2011; Micoulaud-Franchi et al., 2014).
Brain activity can be measured through electroencephalography
(EEG); the technique is thus called EEG-NF. EEG-NF train-
ing aims to achieve self-control over specific aspects of elec-
trical brain activity through real-time feedback and positive
reinforcement and implement these self-regulation skills in daily
life (Heinrich et al., 2007; Gevensleben et al., 2012). There
is growing interest in the use of neurofeedback treatment in
Attention Deficit Hyperactivity Disorder (ADHD) by providing
strategies for better self-regulation and management of some
disturbances of the disorder (Gevensleben et al., 2012; Arns et al.,
2014; Vollebregt et al., 2014b). Nevertheless, NF effectiveness is
one of the most debated subjects in this area at the moment
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(Gevensleben et al., 2012; Arns and Strehl, 2013; Sonuga-Barke
et al., 2013b; Arns et al., 2014; Cannon et al., 2014; Dagenais et al.,
2014; van Dongen-Boomsma, 2014; van Dongen-Boomsma et al.,
2014).
Despite the significant effects of probably not blinded assess-
ment (i.e., an assessment made by an individual likely to be not
blind to treatment, which was in most cases the parent assess-
ment) (Arns et al., 2009), a recent meta-analysis by Sonuga-Barke
et al. (2013a) reported a trend of only four Randomized Con-
trolled Trials (RCT) with semi-active control (i.e., cognitive reme-
diation or electromyographic (EMG)-biofeedback) and sham-NF
groups (i.e., control conditions where everything is identical to
the EEG-NF, except that in this case the feedback is not related to
brain activity) (Arns et al., 2014), with “probably blinded assess-
ment” (i.e., assessment made by an individual likely to be blind to
treatment, which was in most cases assessment made by a teacher)
(Gevensleben et al., 2009b; Bakhshayesh et al., 2011; Lansbergen
et al., 2011; Steiner et al., 2011). Moreover, the effect of the total
score on scale evaluating overall ADHD symptoms with probably
blinded assessment was small (SMD = −0.29 [−0.61, 0.02], p =
0.07) (Sonuga-Barke et al., 2013a). This result was in line with the
previous meta-analysis by Arns et al. (2009) that observed smaller
effects in better-controlled studies (Arns et al., 2009).
Since this later meta-analysis, further RCTs were published
(Arns et al., 2014); because of the methodological issues regard-
ing blinded or unblinded assessment (by parents or teachers)
(Arnold et al., 2013), we decided to further examine the efficacy
of EEG-NF on ADHD in an updated meta-analysis. In addi-
tion, the meta-analysis by Sonuga-Barke et al. (2013a) did not
analyze the inattention and hyperactivity/impulsivity dimensions
separately, which define the three primary subtypes of ADHD:
the predominately inattentive type, the predominantly hyperac-
tive/impulsive type and the combined type (American Psychiatric
Association, 2000; Polanczyk et al., 2007). Thus, we perform
the present meta-analysis on overall ADHD symptoms as well
as the inattention and hyperactivity/impulsivity dimensions for
both probably unblinded assessment (parent assessment) and
probably blinded assessment (teacher assessment). Thus, the aim
of this study was to focus on recent major developments in
the field of NF and ADHD in order to complete and update
the meta-analysis of Sonuga-Barke et al. (2013a) by includ-
ing further RCTs, published after this later meta-analysis with
semi-active control and sham-NF groups to compare the NF
intervention with an intervention that controls for the non-
specific effects of EEG-NF (Arnold et al., 2013; Arns et al.,
2014).
METHODS
We followed the Preferred Reporting Items for Systematic Reviews
and Meta-analyses (PRISMA) recommendations to undertake
the search and analysis of the international scientific literature
(Moher et al., 2009).
We searched PubMed, Embase and Google Scholar databases
for publications between April 2012, the date of search final-
ization of the previous meta-analysis (Sonuga-Barke et al.,
2013a) and August 2014. The following MESH terms were
used: (“Neurofeedback” OR “EEG Biofeedback”) AND (“ADHD”
OR “attention-deficit/hyperactivity disorder”). We also examined
the citation lists of identified publications for additional stud-
ies, used the related articles function of the PubMed database.
English language publications reporting a RCT were eligible
for inclusion. Studies were included if they met the following
criteria:
1. Design: randomized controlled trials (RCT).
2. Intervention: standard protocol EEG-NF with Theta/Beta
Ratio training—TBR (or likely to standard TBR training) or
Slow Cortical Potentials (SCP) training.
3. Control group: semi-active (i.e., cognitive remediation and
EMG-biofeedback) and sham-NF.
4. Participants: participants with an established clinical diagnosis
of ADHD thanks to DSM or CIM criteria.
5. Evaluation of ADHD severity based on a validated scale
with probably blinded assessment (teacher assessment) data
available.
6. No secondary analyses of previously included trials.
Data was independently extracted into a standard elec-
tronic form by two authors (Jean-Arthur Micoulaud-Franchi
and Pierre A. Geoffroy): first author name, date of publica-
tion, country, EEG-NF protocol, number of session, duration
of session, electrode positions, manual or automatic threshold
reward, session of transfer learning strategies in daily life, control
protocols, sample size, mean age, percentage of ADHD males
included, percentage of co-administration of methylphenidate,
parent and teacher ADHD assessment (overall, inattention and
hyperactivity/impulsivity scores).
We calculated a standardized mean difference (SMD) with
95% confidence intervals (CIs) for each study, defined as the
difference in pre-post treatment mean changes between the two
groups (ADHD with EEG-NF vs. control groups) divided by
the pooled standard deviation of the measurements, as previ-
ously performed by Sonuga-Barke et al. (2013a). Random effects
modeling for pooled effect sizes (ES) were used because it
provides a more conservative ES estimate (Hedges and Olkin,
1985; DerSimonian and Laird, 1986). The SMDs were inter-
preted in a similar manner to Cohen’s d (0.2 = small ES;
0.5 = medium ES; 0.8 = large ES). Confidence limit ratios
(CLR = upper-to-lower confidence limit ratio) were calculated
for significant CIs in order to estimate the precision and the
random error (Poole, 2001). The I2 statistic was used to quantify
heterogeneity, with the values of 25%, 50% and 75% reflect-
ing a small, medium or high degree of heterogeneity, respec-
tively (Higgins et al., 2003). We used funnel plots to estimate
by visual inspection the risk of bias (Borenstein et al., 2009).
Forest plots were generated to show SMD with corresponding
CIs for each study and the overall estimate of pooled random
effects. We conducted two subgroups analyses to determine
the impact of probably blinded assessment (teacher assessment)
on ES estimates for EEG-NF effectiveness. Because sensitivity
analysis to test for EEG-NF and clinical characteristics effects
was not possible because of the small number of trials, we
tested the correlation between ES and mean age, percentage
of male, percentage of patient treated with methylphenidate
with Spearman rank correlations. All analyses were performed
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with Review Manager 5.2 software (Cochrane Collaboration,
Copenhagen, Denmark) and SPSS software (Version 18, PASW
Statistics).
RESULTS
RESULTS OF THE LITERATURE SEARCH
Twelve RCTs were published since April 2012. We excluded one
study with a non-standard EEG-NF protocol (Arnold et al., 2013),
five studies with non-semi-active or sham-NF control groups (i.e.,
treatment as usual or methylphenidate) (Li et al., 2013; Ogrim and
Hestad, 2013; Bink et al., 2014; Meisel et al., 2014) and one study
with no available probably blinded assessment data (Duric et al.,
2012). Two studies were excluded because there were secondary
analyses of already included RCTs (Steiner et al., 2014a; Vollebregt
et al., 2014a).
Three studies from April 2012 to August 2014 (van Dongen-
Boomsma et al., 2013; Maurizio et al., 2014; Steiner et al., 2014b)
were eligible for inclusion. The previous meta-analysis by Sonuga-
Barke et al. (2013a) included four RCTs (Gevensleben et al.,
2009b; Bakhshayesh et al., 2011; Lansbergen et al., 2011; Steiner
et al., 2011). We excluded studies that would lead us to pool data
to avoid including the same patients more than once. Indeed,
two studies eligible for inclusion in the present meta-analysis
(van Dongen-Boomsma et al., 2013; Steiner et al., 2014b) were
continuations of pilot studies included in the meta-analysis of
Sonuga-Barke et al. (2013a) (Lansbergen et al., 2011; Steiner et al.,
2011). These two pilot studies were not included in the present
meta-analysis.
At the end of this RCT selection process, five studies were
retained for quantitative analysis: two from the previous meta-
analysis of Sonuga-Barke et al. (2013a) (Gevensleben et al., 2009b;
Bakhshayesh et al., 2011) and three recently published RCTs (van
Dongen-Boomsma et al., 2013; Maurizio et al., 2014; Steiner et al.,
2014b).
RESULTS OF THE META-ANALYSIS
Studies and populations characteristics
Overall, 263 patients with ADHD were included vs. 179 in the
meta-analysis of Sonuga-Barke et al. (2013a), the mean age
range was 8.4–10.6 years, the range of the male percentages
was 67.6–96.3% and the range of the children percentages tak-
ing methylphenidate was 0–50%. One hundred and forty-six
patients vs. 103 in the meta-analysis of Sonuga-Barke et al.
(2013a) were trained with EEG-NF. Four trials studied TBR
training (Bakhshayesh et al., 2011; Maurizio et al., 2014; Steiner
et al., 2014b) or likely to standard TBR training (van Dongen-
Boomsma et al., 2013), one used the combination of both:
TBR training and training of SCP (Gevensleben et al., 2009b).
Sixty-nine controls received cognitive remediation (Gevensleben
et al., 2009b; Steiner et al., 2014b) and 48 controls received
sham-NF (van Dongen-Boomsma et al., 2013) or EMG biofeed-
back (Bakhshayesh et al., 2011; Maurizio et al., 2014). Three
differents ADHD scales were used: the German ADHD Rat-
ing Scale, the ADHD Rating Scale and the Conners’ Rating
Scale. Table 1 summarizes the characteristics of the included
studies.
Effects of EEG-NF on parent assessment (probably no-blinded
assessment)
The overall ADHD score (SMD = −0.49 [−0.74, −0.24],
CLR = 3.08, p < 0.001), the inattention score (SMD = −0.46
[−0.76, −0.15], CLR = 3.04, p = 0.003) and the
hyperactivity/impulsivity score (SMD = −0.34 [−0.59, −0.09],
CLR = 6.55, p = 0.007) were significantly improved in patients
receiving EEG-NF compared to controls. The three associated
funnel plots were reasonably symmetrical excluding publication
biases (Figure 1).
Effect of EEG-NF on teacher assessment (probably blinded
assessment)
The inattention score was significantly improved in patients
receiving EEG-NF compared to controls (SMD = −0.30 [−0.58,
−0.03], CLR = 19.33, p = 0.03). No significant effect was found on
the overall ADHD score (SMD = −0.18 [−0.42, 0.07], p = 0.15)
and the hyperactivity/impulsivity score (SMD = −0.14 [−0.39,
0.10], p = 0.26). The three associated funnel plots were reasonably
symmetrical excluding publication biases (Figure 1).
Sensitivity analysis to test for medication effects
A significant correlation was found between the ES on the overall
ADHD score assessed by teacher and percentage of patient treated
with methylphenidate (rs[5] = 0.9, p = 0.037). The more the effect
size is negative (i.e., in favor of EEG-NF), the less the percentage
of patient treated with methylphenidate. No other significant
correlation between ES and EEG-NF and clinical characteristics
was found.
DISCUSSION
The major findings of this updated meta-analysis are that:
(i) EEG-NF significantly improves the ADHD total score on
a parent-assessment scale with a medium effect size of −0.49;
(ii) EEG-NF significantly improves both the inattention and
hyperactivity/impulsivity dimensions on a parent-assessment
scale with medium effect sizes of −0.46 and −0.34, respectively;
and (iii) EEG-NF significantly improves the inattention dimen-
sion on a teacher-assessment scale with a smaller effect size
of−0.30.
Our results confirmed the findings provided by the meta-
analysis of Sonuga-Barke et al. (2013a) on the overall ADHD
score with a medium effect size of −0.59 on a probably blinded
assessment and of −0.29 on a probably unblinded assessment.
Note that for overall scores on a probably unblinded assessment,
the CLR was 3.08 similar as in Sonuga-Barke et al. (2013a). In
our study, CLR was 3.04 for the inattention dimension with a
probably unblinded assessment, and was higher with a probably
blinded assessment (19.33). This result indicates that probably
blinded assessment is influenced more by random error and
is more unstable than unblinded assessment. Thus, the evi-
dence supporting EEG-NF interventions was influenced by the
probable blindness status of the assessor (probably unblinded
parent vs. probably blinded teacher). These results suggest that
EEG-NF should be evaluated by at least one probably blinded
assessor.
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FIGURE 1 | Forest plots with Standardized Mean Difference (SMD), effect size, and homogeneity statistics for the meta-analysis examining total
scores of ADHD symptoms, inattention dimension and hyperactivity/Impulsivity dimension assessed by parent (left) and by teacher (right).
The methodological strength and novelty of the present
updated meta-analysis was to combine stringent inclusion crite-
ria similar to the meta-analysis of Sonuga-Barke et al. (2013a)
with the additional consideration of the inattention and hyper-
activity/impulsivity dimensions. These precautions allow us to
observe the effects of evidence-supporting EEG-NF on inatten-
tion symptoms in ADHD in both probably unblinded parents
and probably blinded teacher assessments with similar effect sizes.
On the contrary, EEG-NF was found to be effective in hyper-
activity/impulsivity only in probably unblinded parent assess-
ments. These results emphasize those of Arns et al. (2009), who
observed a smaller size effect for the hyperactivity dimension
than for the inattention dimension. Though moderate, the effect
size remains significant in our meta-analysis compared to the
large effect size observed by Arns et al. (2009). It could be
explained by the fact that some trials included in our meta-
analysis attempt to blind parents to treatment allocation by
using sham NF (van Dongen-Boomsma et al., 2013) or EMG
biofeedback with comparable electrode placement to EEG-NF
(Bakhshayesh et al., 2011; Maurizio et al., 2014). This improved
blinded methodology can diminish the risk of rater bias con-
cerning the placebo effect of electronic devices (Schwitzgebel and
Traugott, 1968; Stroebel and Glueck, 1973) and should thus be
encouraged in further studies (Arnold et al., 2013; Arns et al.,
2014).
The effect size in favor of EEG-NF to treat the inattention
dimension of ADHD confirms the standard target of the EEG-
NF protocol. EEG-NF, through the TBR or SCP training pro-
vides immediate feedback on how the brain is focusing. Thus,
these protocols are classically known to reinforce the state of
attention (focused and attentive but relaxed) (Monastra et al.,
2005; Sherlin et al., 2011; Arns et al., 2014). The significant
correlation between the teacher-assessed overall ADHD score and
methylphenidate treatment could also be explained by the fact
that methylphenidate decreases the TBR in children, exhibiting
a positive medication response (Loo et al., 1999). As it was
determined that low TBR at baseline was a negative predictor
for EEG-NF (Gevensleben et al., 2009a; Arns et al., 2012), this
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pharmacological EEG enhancement could reduce the possibil-
ity of training on this parameter during a session of EEG-
NF (Sherlin et al., 2011). Thus, further studies should analyze
the relationship between TBR at baseline and the enhancement
of inattention after an EEG-NF intervention and the effect of
methylphenidate on performance during EEG-NF training in
children with ADHD.
The principal limitations of our meta-analysis include the
small number of studies, the relatively small number of subjects
enrolled in the individual studies, and the heterogeneous
methodology concerning the characteristics of the EEG-NF
protocols (Table 1). As we conducted an updated meta-analysis of
Sonuga-Barke et al. (2013a) by including further RCTs according
to similar criteria of inclusion and exclusion, we included
only a small number of studies insufficient in order to explore
potential reasons of heterogeneity between other studies with less
conservative inclusion criteria. Moreover, the inclusion of the van
Dongen-Boomsma et al. (2014) study in our meta-analysis could
be discussed in line with the debate concerning the inclusion
of the Lansbergen et al. (2011) study in the meta-analysis of
Sonuga-Barke et al. (2013a) (Arns and Strehl, 2013; Sonuga-
Barke et al., 2013b; Arns et al., 2014; Cannon et al., 2014; van
Dongen-Boomsma, 2014; van Dongen-Boomsma et al., 2014).
The EEG-NF protocol of the pilot study of van Dongen-Boomsma
et al. (2013) was considered to be non-standard (Arns and Strehl,
2013; Arns et al., 2014; Cannon et al., 2014). However, we decided
to include the van Dongen-Boomsma et al. (2013) study because
two changes were made (manually adjusted reward thresholds and
transfer learning strategies in daily life) that bring their EEG-NF
protocol closer to a standard TBR protocol (Sherlin et al., 2011).
The inclusion of the Maurizio et al. (2014) study in our
meta-analysis could be also a subject of discussion because it uses
a tomographic EEG-NF that is rarely used in a clinical context.
However, we decided to include this study because this training
protocol was very close to standard TBR protocol on scalp-level
EEG-NF. The main difference was the higher spatial resolution
with tomographic EEG-NF. Such studies should be encouraged
because it targeted more precisely the brain region known to be
affected in ADHD and could increase the efficacy of EEG-NF
(Micoulaud-Franchi et al., 2014).
Lastly, the non-inclusion of Arnold et al. (2013) study in our
meta-analysis could be criticized. Nonetheless, as the authors
highlighted in their limitation (Arnold et al., 2013), the protocol
used was not based on the basic learning theory (in particular
by the type of reinforcement) used in standard EEG-NF protocol
(Sherlin et al., 2011).
This debate, concerning the choice of studies included in EEG-
NF meta-analysis, highlights the importance of investigating the
efficacy of EEG-NF in children with ADHD with adequately
blinded studies as well as EEG-NF protocols that carefully control
the implementation and embedding of training concerning the
EEG target, reward feedback, learning during the sessions and
transfer learning in daily life (Sherlin et al., 2011; Vollebregt et al.,
2014b).
Another possible limit of our approach was to link prob-
ably blinded assessments to teacher assessments and probably
unblinded assessments to parent assessments. Bralten et al. (2013)
observed that the associations with genetics were stronger for par-
ent assessment of ADHD symptoms than for teacher assessments.
Because of the few number of studies using EMG-biofeedback or
sham-NF as control group, we lacked the possibility to provide
the meta-analysis with probably blinded parent assessments. Such
studies are to be strongly encouraged and could afford more
reliable and valid assessments than probably blinded teacher
assessments to evaluate the efficacy of EEG-NF (Bralten et al.,
2013).
In conclusion, this meta-analysis using stringent inclusion cri-
teria is the third EEG-NF intervention that confirms the efficacy
of EEG-NF when ADHD symptoms are assessed by parents (e.g.,
with a unblinded assessment). This is also the first meta-analysis
that suggests the persistence of EEG-NF efficacy only for the
inattention dimension of ADHD when considering recent well-
controlled studies that include semi-active and sham-NF controls,
as well as probably blinded assessment of inattention symptoms.
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